Background: Red cell distribution width (RDW) is a marker of iron-deficient anaemia that can also assist differentiation of other anaemias. RDW also has been suggested as an effective marker for earlier anaemia detection. The RDW-anaemia relationship was investigated in cross-sectional community patient data, and the capacity of RDW to predict the diagnostic value of second tier anaemia markers assessed. Methods: Routine and second tier assay data were provided by the laboratory Sullivan Nicolaides Pathology. The cohort was divided into male and female groups stratified by age, and correlation analyses assessed associations of RDW to haemoglobin and ferritin. Analysis of covariance (ANCOVA) was performed for both routine and second tier markers to investigate their significance for RDW prediction.
Introduction
Red cell distribution width (RDW) is the standard deviation or coefficient of variation percent (CV%) of the red blood cell (RBC) volume that is determined by an automated haematology analyser, calculated from the mean corpuscular volume (MCV) . Erythrocytes are typically 6-8 μm in diameter, and for some anaemias there are significant variations in cell size. Higher RDW values indicate greater variation in red cell size (anisocytosis) [1] , which is caused by problems with the production or destruction of the erythrocytes. RDW is used with other full blood count/ complete blood count (FBC/CBC) indices to diagnose anaemia, and if indicated, additional specialised second tier tests of iron metabolism and storage (e.g., ferritin), and nutritional markers (e.g., vitamin B12), will be requested to classify the cause of the anaemia and guide subsequent treatment. The RDW is elevated in macrocytic anaemias and nearly all cases of iron deficiency anaemia (IDA), and has been found as valuable for differentiating thalassaemia from iron deficiency [2] .
However, an elevation in the RDW is not characteristic of all anaemias, for example, the anaemia of chronic disease, hereditary spherocytosis, acute blood loss, aplastic anaemia, and certain hereditary haemoglobinopathies present with a normal RDW [3] . RDW has been also associated with the estimation of mortality due to cancer, heart or respiratory disease, as well as "all cause" mortality, for intensive care and other patients [4] [5] [6] , as well as liver and renal conditions [1, 7] , suggesting a wider diagnostic utility beyond anaemia.
A clinical update by Dugdale [8] reported an inverse relationship of RDW (CV%) with haemoglobin concentration that developed over several months, and noted that increases in RDW preceded clinically significant haemoglobin decreases by several weeks, hence proposing that RDW be considered as a valuable routine marker for the early detection of iron-deficient anaemia (IDA). In addition, it was suggested that while ferritin and folate are "gold-standard" tests for anaemia, these second tier tests are "complex and expensive", while RDW can be easily calculated from routine haematology profiles at no additional cost. Motivated by this observation, the aims of this study were to validate the RDW/Haemoglobin relationship in a large cohort of community patients, and secondly investigate whether RDW had significant associations with second tier anaemia tests in males and females of reproductive and post -reproductive age ranges. As a practical laboratory diagnosis consideration, the potential for RDW to provide a specific anaemia diagnosis without resort to expensive and time consuming second tier tests, was of additional interest.
Materials and methods

Data
Cross-sectional pathology data from female and male community patients were provided by the diagnostics laboratory, Sullivan Nicolaides Pathology (Brisbane, Australia) and represented individuals investigated for anaemia over August -September 2012. Routine full blood count (FBC/CBC) profiles and second tier laboratory tests associated with the investigation of anaemia were included; specifically serum ferritin, serum iron, vitamin B12, red cell folate (RCF), transferrin and saturation. Laboratory reference ranges for routine and second tier anaemia markers are listed in Table 1 . Results for routine markers were collected on the Sysmex XE2100 platform (Roche Diagnostics, Sydney), while ferritin, serum iron were measured on the Roche Modular (Roche Diagnostics, Sydney Australia). Reference interval applies to an age range of 14-> 100 years for males and females.
From the total cases provided (n = 8760), data were selected in the age range of 15-50 years and then separated into female (n = 1770) and male (n = 686) cases. From this, data were further sorted into cases that comprised both routine and second tier blood test data required for investigation of anaemia in individual female (n = 744) and male (n = 215) cases. An identical process was performed for female and male cases of 55 years of age and older (total number of cases investigated were: females: n = 1892; males: n = 1076).
Human Ethics approval for this project was granted by Committees from both Bond University and The Australian National University.
Statistical analysis
Pearson's correlation was performed for the analysis of RDW and haemoglobin relationships. Correlation analysis of the RDW vs. serum ferritin relationship was conducted by the non-parametric Spearman's correlation method, given the non-linear relationship between these two variables.
All investigations of RDW variation were conducted by analysis of covariance (ANCOVA) with ferritin assigned as a fixed binary factor; female ferritin category thresholds were set at less or greater than 40 ng/mL, and male thresholds at less or greater than 100 ng/mL, informed by scatter plots that showed a "broken stick", "hockey stick" or piecewise linear relationship between RDW and linear serum ferritin, which was particularly pronounced for young females.
Separate ANCOVA were performed for routine erythrocyte indices and second tier anaemia markers. Haemoglobin, linear serum ferritin and binary ferritin category were included as predictor variables for all analyses. Prior to ANCOVA, colinearity among predictor variables was assessed by Pearson's correlation (two-tails) and variation inflation factor (VIF), with highly colinear predictor variables (VIF > 10) removed from the model before analysis (MCV was not included as a predictor variable for any analysis). All correlations and ANCOVA were performed using SPSS version 21.
Results
RDW relationship to haemoglobin and ferritin
Pearson's correlation analysis of RDW in relation to haemoglobin (Hb) was conducted for females and males of both age ranges examined. Supporting the previous observation by Dugdale [8] , Hb had a significant negative association (p < 0.01) with RDW for each sex and age range examined ( Figure 1A-D) . The majority of individuals within each community population examined fell inside the reference ranges for both RDW and haemoglobin, as seen as a tight cluster for each scatterplot. The plots also detected occasional individual cases that had normal haemoglobin but elevated RDW, or low haemoglobin and RDW within the reference range, suggesting other disorders besides iron-deficient anaemia [9, 10] . The strength of correlation (r) ranged between -0.38 to -0.43 for both female groups and older males, with younger (15-50 years) males weaker than -0.30.
As the "gold-standard" for the diagnosis of iron deficient anaemia (IDA), serum ferritin was considered carefully as a predictor of RDW variation. For females and males of > 55 years, and females between 15 and 50 years, significant (p < 0.001) negative correlations (r = -0.14-0.29) were found for RDW and ferritin. A weaker, but significant negative correlation was also found for 15-50 years males (r = -0.15; p = 0.031). Plots of RDW and ferritin ( Figure  2A -2D) showed non-linear relationships, particularly for both female cohorts, and suggested two distinct subpopulations of ferritin response in relation to RDW measurement, defined by a greater range of RDW responses for ferritin concentrations less than 40 ng/mL. For subsequent ANCOVA, binary ferritin category was introduced into the RDW models to control for the two distinct populations. The impact of ferritin for the RDW models presented is summarised in Tables 2 and 3 .
Determination of RDW variation predictors by ANCOVA models examining routine red cell indices and second tier tests for anaemia diagnosis
ANCOVA modelling showed strong associations between RDW and Hb, red cell count and MCHC for both sexes and age ranges, with age also strongly associated with RDW for females of both age ranges and males greater than 55 years of age (Tables 2 and 3 ). Model adjusted R 2 values ranged between 0.311-0.403 for female and male RDW models of routine red cell markers and ferritin, but were weaker for models of ferritin, haemoglobin and second tier anaemia markers, ranging from R 2 0.058 to 0.258. Caution must be exercised particularly when interpreting second tier models for men ranging in age from 15 to 50 years (R 2 = 0.058) and women greater than 55 years of age (R 2 = 0.100). The gold-standard special test for iron-deficient anaemia, serum ferritin, was examined in ANCOVA models as both a linear and categorical predictor variable due to its curved distribution pattern in relation to RDW (Figure 2 ). Ferritin was a significant predictor of RDW only for females in the 15-50 year age group, and only as a categorical predictor variable. Neither linear nor categorical ferritin showed a significant relationship with RDW for women older than 55 years, or males of either age range (Tables 2 and 3 ). The results suggest therefore, that ferritin should be considered as a leading primary diagnostic test for women of reproductive age, and not for men and postmenopausal women.
Additional second tier measures of iron status (serum iron, saturation, transferrin) were also considered for ANCOVA models. Transferrin and serum iron measurements were significant RDW predictors for both male cohorts and women from 15 to 50 years of age, but not older women. Vitamin B12 and red cell folate (RCF) were also included in ANCOVA models, and confirming the primacy of RDW as a marker for iron-deficient anaemia, in general were not significant RDW predictors. However, vitamin B12 was found as a very significant (p = 0.001) RDW predictor for men aged 55 years and older, possibly extending the diagnostic capacity of RDW beyond iron deficiency for older men.
A longitudinal case study of RDW, haemoglobin, MCV and ferritin interaction concentrations (Table 1 ). When RDW reached its peak of 32.6%, haemoglobin and MCV concentrations were recovering towards healthy, non-anaemic values. The next round of tests, conducted 8 months after the RDW peak, reported all red cell indices and RDW within their specific reference intervals, with corresponding serum ferritin measured at 20 ng/mL. Presumably therapy was attempted for this patient that may explain aspects of the observed red cell and iron marker kinetics, but clinical notes were not available to comment with certainty.
Discussion
The analyses presented confirmed Dugdale's previously reported relationship between increasing RDW and decreasing Hb [8] , but in cross-sectional data representing hundreds of community patients. This was further explored and confirmed by a longitudinal case study (Figure 3 ) that demonstrated the inverse relationship between RDW and Hb over time, as well as the associated long-term perturbations of MCV and serum ferritin for the same female community patient. The long term, longitudinal kinetics of RDW with other routine and second tier markers were performed on several female community patients, with various response patterns identified; the further analysis of these RDW kinetics will be the subject of a separate future investigation.
The capacity of routine RDW measurements to predict the importance of second tier anaemia markers (e.g., ferritin, vitamin B12), and hence likely anaemia aetiology, was the subject of ANCOVA. The observation that RDW had a broken stick distribution in relation to serum ferritin necessitated the choice of ANCOVA, rather than linear regression, since ferritin could be introduced as a categorical variable in an analysis that included several continuous predictor (explanatory) variables [11] , and thus controlled for the impact of the non-linear RDW-ferritin Ferritin categories: 15-50 years of age (Category 0 = 5-40 ng/mL) (n = 240): (Category 1 = 41-350 ng/mL) (n = 504). ≥ 55 years of age (Category 0 = 6-40 ng/mL) (n = 301): (Category 1 = 41-399 ng/mL) (n = 1505). Ferritin categories: 15-50 years of age (Category 0 = 7-99 ng/mL) (n = 55): (Category 1 = 100-400 ng/mL) (n = 159). ≥ 55 years of age (Category 0 = 5-99 ng/mL) (n = 379): (Category 1 = 100-400 ng/mL) (n = 695).
known [12] , however the low correlation with transferrin in the older group has not been reported previously. In general, RCF and vitamin B12 were not significant predictors of RDW variation, however, vitamin B12 was found as a significant RDW predictor for men of 55 years of age or older; a previous study has supported RDW sensitivity to detecting B12 deficiency [13] . This male sex and age connection of RDW with vitamin B12 warrants further investigation as it may reflect wider health concerns for older men, for example nutritional status and associated behaviours. Beyond anaemia diagnosis, there is compelling evidence that RDW is also valuable for other health conditions, with a particularly strong interest in RDW and cardiac disease, and longer-term implications for subsequent morbidity and mortality. RDW has been reported to be a prognostic marker in chronic heart failure [14] with an increased morbidity and mortality of an adjusted hazard ratio of 1.17 per 1 SD above normal [15] . Of additional interest to cardiac health and morbidity/mortality was the useful role of RDW when monitoring patients post ST elevation infarction [16] , and for outcomes post cardiac catheterisation [17] , as well as a range of other cardiac assessments, including acute myocardial infarction in young patients [18] [19] [20] [21] . There has been evidence that the RDW may predict mortality in newly hospitalised patients, critically ill patients and in older community patients [4, [22] [23] [24] [25] , with RDW also a marker of diabetes in the elderly through a HbA1c association [26] . Increased RDW also may be a useful marker for the assessment of liver function, with associations noted for both non-alcoholic steatohepatitis and fibrosis [27] , and HBV induced liver cirrhosis [28] . Underpinning RDW associations with the diverse array of disease is a likely link to increased inflammation [3, 29] and disrupted erythropoiesis. RDW has been suggested as a marker of oxidative stress or physiological reserve [25] , which suggests that under acute cellular stress and resultant tissue hypoxia, there would be increased production and release of mature erythrocytes into the peripheral blood stream. The release of large immature red cells with poor oxygen binding capacity would lead to increasing RDW that implies a suboptimal response to oxidative stress, and a poor clinical outcome. Investigating the role of inflammation in coronary heart disease, studies have combined RDW with C-reactive protein (CRP) to enhance mortality prediction [30, 31] .
As previously observed [8] , RDW has a significant negative correlation with haemoglobin that provides for the early detection of iron-deficient anaemia (IDA) well in advance of clinically significant decreases in longitudinal Hb measurements, but often is not presented routinely on relationship. As a predictor of RDW, ferritin was only statistically significant for younger (15-50 years) women, and confirming the choice of ANCOVA, was only significant as a categorical, not linear, predictor variable. Serum ferritin was not a significant RDW predictor for older women ( > 55 years), nor men of either age range investigated. Serum iron and transferrin were consistent RDW predictors among the second tier tests (but transferrin was not significant for > 55 years women). The strong correlation between these iron sufficiency markers and RDW is well laboratory reports. In further exploring the utility of RDW for early detection of anaemia, ANCOVA models were conducted on cross-sectional community patient data to assess whether RDW also could give early indications of anaemia aetiology, and perhaps reduce the need to perform additional second tier tests. As the gold-standard second tier test for IDA, serum ferritin was included in all ANCOVA with separate models conducted for routine and second tier test covariates, in data stratified by age and sex. Interestingly ferritin was not universally significant, with some variations in RDW predictor patterns found for different age and sex. RDW can be elevated in the absence of iron, folate or B12 deficiency, blood loss or haemoglobinopathies [11] . In evaluating RDW as an early marker for anaemia and its cause, several other health conditions that alter RDW need to be considered as well, which could be eliminated by access to clinical notes and other laboratory results (e.g., troponin); this study did not have access to clinical notes to screen for cardiac or other comorbidities that influence RDW. From the results presented here, RDW variation for younger women (15-50 years) was largely explained by iron-deficiency, whereas the significance of RDW in the older cohorts may be more closely associated with immune/inflammatory function connected with physiological stress, and disordered haematopoiesis. In a broader conceptual sense, this study demonstrated the value of looking at routine laboratory results as a total marker network, rather than only specific tests that are traditionally considered to be directly diagnostic for a disease. Subtle changes in laboratory result patterns, including changes within a reference interval, may reveal insights into pathological processes dictated by relationships with other disease markers in data networks investigated. Results from this and similar studies, once validated will augment laboratory diagnosis, as well as possibly modify the need for second tier testing with some health conditions.
